Future ICT, AI, Computing and IoT in Support of Microbiology and Infectious D...CrimsonpublishersCJMI
ย
Future ICT, AI, Computing and IoT in Support of Microbiology and Infectious Diseases Treatment by Eduard Babulak in Cohesive Journal of Microbiology & Infectious Disease
Biotechnology and Medicine: Global Perspective
Gundu H R Rao, PhD
Emeritus Professor, Laboratory Medicine and Pathology, Anesthesiology, Lillehei Heart Institute, and Biomedical Engineering Institute, University of Minnesota, Minneapolis, Minnesota, USA 55455.
Gundurao9@gmail.com
There are more than 3000 biotech companies in the world. However, reliable sources indicate that only about 100 out of these 3000 companies, are offering commercial products. Majority of them depend on public or private funding for sustaining their operations. Of the 100 top biotech companies listed in Wikipedia, 70% of them are US companies. Only one from India and one from China are listed in this list of top 100 companies. The revenue generated ranges from a high of 15,000 million dollars to less than a few million dollars. Advance in biotechnology and biomedicine has contributed significantly, to the increased revenues in animal and agricultural products worldwide. Similarly, there is significant contribution in tissue engineering, drug discovery and development, development of biomarker assays for diagnostics, management of therapies, cellular and molecular therapies. China, one of the fastest developing economies, has initiated exchange program with 152 countries and signed memorandum of understanding with 96 countries, to become one of the major players in this field. One of the earliest and most significant biotechnology revolutions is the development of dairy industry in India. In the area of agriculture, India is the worldโs largest producer of sugar and sugarcane (285 million tones). India is the second largest producer of Potatoes in the world, after China. In the area of biomedicine, India produces 60% of the global health vaccines (USD 665Million) using the World Health Organization protocols. The growth of Biotechnology and biomedicine in India is sporadic. Department of Biotechnology, Government of India, feels that it is time now, to develop a well thought-out, robust, state-of-the-art biotechnology and biomedicine program in India. In this overview, I will share my concept of how these technologies should be developed in India, to meet the needs of the country as well as to be globally competitive.
It gives me great pleasure to share some of my thoughts with you all, on these two very important topics: biotechnology and biomedicine. Biotechnology as we know today contributes significantly, to the growth and progress of research, in all of the areas selected for discussion, under various โsub-themesโ for this international conference. The priority areas include, basic biology, biomedicine, bio-agriculture, bioenvironmental technology, biodiversity and bio-safety. Government of India has established a biotech park in Lucknow (UP), which houses 16 entrepreneurs, a Genome valley in Hyderabad, which is well supported by the State Government. Government of India also has approved the establishment of biotech parks in the States of Karn
Future ICT, AI, Computing and IoT in Support of Microbiology and Infectious D...CrimsonpublishersCJMI
ย
Future ICT, AI, Computing and IoT in Support of Microbiology and Infectious Diseases Treatment by Eduard Babulak in Cohesive Journal of Microbiology & Infectious Disease
Biotechnology and Medicine: Global Perspective
Gundu H R Rao, PhD
Emeritus Professor, Laboratory Medicine and Pathology, Anesthesiology, Lillehei Heart Institute, and Biomedical Engineering Institute, University of Minnesota, Minneapolis, Minnesota, USA 55455.
Gundurao9@gmail.com
There are more than 3000 biotech companies in the world. However, reliable sources indicate that only about 100 out of these 3000 companies, are offering commercial products. Majority of them depend on public or private funding for sustaining their operations. Of the 100 top biotech companies listed in Wikipedia, 70% of them are US companies. Only one from India and one from China are listed in this list of top 100 companies. The revenue generated ranges from a high of 15,000 million dollars to less than a few million dollars. Advance in biotechnology and biomedicine has contributed significantly, to the increased revenues in animal and agricultural products worldwide. Similarly, there is significant contribution in tissue engineering, drug discovery and development, development of biomarker assays for diagnostics, management of therapies, cellular and molecular therapies. China, one of the fastest developing economies, has initiated exchange program with 152 countries and signed memorandum of understanding with 96 countries, to become one of the major players in this field. One of the earliest and most significant biotechnology revolutions is the development of dairy industry in India. In the area of agriculture, India is the worldโs largest producer of sugar and sugarcane (285 million tones). India is the second largest producer of Potatoes in the world, after China. In the area of biomedicine, India produces 60% of the global health vaccines (USD 665Million) using the World Health Organization protocols. The growth of Biotechnology and biomedicine in India is sporadic. Department of Biotechnology, Government of India, feels that it is time now, to develop a well thought-out, robust, state-of-the-art biotechnology and biomedicine program in India. In this overview, I will share my concept of how these technologies should be developed in India, to meet the needs of the country as well as to be globally competitive.
It gives me great pleasure to share some of my thoughts with you all, on these two very important topics: biotechnology and biomedicine. Biotechnology as we know today contributes significantly, to the growth and progress of research, in all of the areas selected for discussion, under various โsub-themesโ for this international conference. The priority areas include, basic biology, biomedicine, bio-agriculture, bioenvironmental technology, biodiversity and bio-safety. Government of India has established a biotech park in Lucknow (UP), which houses 16 entrepreneurs, a Genome valley in Hyderabad, which is well supported by the State Government. Government of India also has approved the establishment of biotech parks in the States of Karn
Introduction to Biotechnology in India-History and Evolution. Brief Discussion about Current scenario and scope of Biotechnology in India and top companies.
What Next After B.Sc., Biotechnology and Microbiology Avenues / CareersDr. Pavan Kundur
ย
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers,
Here i tried to compile all the future opportunities in biotechnology and microbiology
Vibrant Gujarat Summit Profile for Biotechnology and Nano Technology SectorVibrant Gujarat
ย
The Indian biotechnology sector is one of the fastest growing knowledgeโbased sectors in India and is expected to play a key role in shaping India's rapidly developing economy.
The Indian Biopharmaceutical segment holds the largest market share in the Biotech Industry in India and continues to grab the highest share of the entire Biotechnology sector.
The government plans to strengthen regulatory science and infrastructure, which involves setting up of Biotechnology Regulatory Authority of India (BRAI) and a central agency for regulatory testing and certification laboratories.
Maharashtra Industrial Policy 2013
The fresh policy for Industrial Investment in Maharashtra.
You can recover upto 70 % of your total investment with Incentives for Industries with high : Capital Investment, Tax, CST and Vat Payment, Energy or Electricity and water consumption.
Introduction to Biotechnology in India-History and Evolution. Brief Discussion about Current scenario and scope of Biotechnology in India and top companies.
What Next After B.Sc., Biotechnology and Microbiology Avenues / CareersDr. Pavan Kundur
ย
What Next After B.Sc., Biotechnology and Microbiology Avenues / Careers,
Here i tried to compile all the future opportunities in biotechnology and microbiology
Vibrant Gujarat Summit Profile for Biotechnology and Nano Technology SectorVibrant Gujarat
ย
The Indian biotechnology sector is one of the fastest growing knowledgeโbased sectors in India and is expected to play a key role in shaping India's rapidly developing economy.
The Indian Biopharmaceutical segment holds the largest market share in the Biotech Industry in India and continues to grab the highest share of the entire Biotechnology sector.
The government plans to strengthen regulatory science and infrastructure, which involves setting up of Biotechnology Regulatory Authority of India (BRAI) and a central agency for regulatory testing and certification laboratories.
Maharashtra Industrial Policy 2013
The fresh policy for Industrial Investment in Maharashtra.
You can recover upto 70 % of your total investment with Incentives for Industries with high : Capital Investment, Tax, CST and Vat Payment, Energy or Electricity and water consumption.
Maharashtra Industrial Policy 2013
Package Scheme of Industries is a document detailing the Incentives for New Industrial Investment in the state of Maharashtra.
The fresh policy for Industrial Investment in Maharashtra.
You can recover upto 70 % of your total investment with Incentives for Industries with high : Capital Investment, Tax, CST and Vat Payment, Energy or Electricity and water consumption.
Maharashtra Industrial policy of 2013, Incentives for Investment.Bakul Haria
ย
The fresh policy for Industrial Investment in Maharashtra.
You can recover upto 70 % of your total investment with Incentives for Industries with high : Capital Investment, Tax, CST and Vat Payment, Energy or Electricity and water consumption.
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
ย
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Improving profitability for small businessBen Wann
ย
In this comprehensive presentation, we will explore strategies and practical tips for enhancing profitability in small businesses. Tailored to meet the unique challenges faced by small enterprises, this session covers various aspects that directly impact the bottom line. Attendees will learn how to optimize operational efficiency, manage expenses, and increase revenue through innovative marketing and customer engagement techniques.
"๐ฉ๐ฌ๐ฎ๐ผ๐ต ๐พ๐ฐ๐ป๐ฏ ๐ป๐ฑ ๐ฐ๐บ ๐ฏ๐จ๐ณ๐ญ ๐ซ๐ถ๐ต๐ฌ"
๐๐ ๐๐จ๐ฆ๐ฌ (๐๐ ๐๐จ๐ฆ๐ฆ๐ฎ๐ง๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
๐๐ ๐๐จ๐ฆ๐ฌ provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
โญ ๐ ๐๐๐ญ๐ฎ๐ซ๐๐ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐ฌ:
โข 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
โข SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
โขFreenBecky 1st Fan Meeting in Vietnam
โขCHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
โข WOW K-Music Festival 2023
โข Winner [CROSS] Tour in HCM
โข Super Show 9 in HCM with Super Junior
โข HCMC - Gyeongsangbuk-do Culture and Tourism Festival
โข Korean Vietnam Partnership - Fair with LG
โข Korean President visits Samsung Electronics R&D Center
โข Vietnam Food Expo with Lotte Wellfood
"๐๐ฏ๐๐ซ๐ฒ ๐๐ฏ๐๐ง๐ญ ๐ข๐ฌ ๐ ๐ฌ๐ญ๐จ๐ซ๐ฒ, ๐ ๐ฌ๐ฉ๐๐๐ข๐๐ฅ ๐ฃ๐จ๐ฎ๐ซ๐ง๐๐ฒ. ๐๐ ๐๐ฅ๐ฐ๐๐ฒ๐ฌ ๐๐๐ฅ๐ข๐๐ฏ๐ ๐ญ๐ก๐๐ญ ๐ฌ๐ก๐จ๐ซ๐ญ๐ฅ๐ฒ ๐ฒ๐จ๐ฎ ๐ฐ๐ข๐ฅ๐ฅ ๐๐ ๐ ๐ฉ๐๐ซ๐ญ ๐จ๐ ๐จ๐ฎ๐ซ ๐ฌ๐ญ๐จ๐ซ๐ข๐๐ฌ."
Business Valuation Principles for EntrepreneursBen Wann
ย
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
ย
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Putting the SPARK into Virtual Training.pptxCynthia Clay
ย
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
ย
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
Attending a job Interview for B1 and B2 Englsih learnersErika906060
ย
It is a sample of an interview for a business english class for pre-intermediate and intermediate english students with emphasis on the speking ability.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Cracking the Workplace Discipline Code Main.pptxWorkforce Group
ย
Cultivating and maintaining discipline within teams is a critical differentiator for successful organisations.
Forward-thinking leaders and business managers understand the impact that discipline has on organisational success. A disciplined workforce operates with clarity, focus, and a shared understanding of expectations, ultimately driving better results, optimising productivity, and facilitating seamless collaboration.
Although discipline is not a one-size-fits-all approach, it can help create a work environment that encourages personal growth and accountability rather than solely relying on punitive measures.
In this deck, you will learn the significance of workplace discipline for organisational success. Youโll also learn
โข Four (4) workplace discipline methods you should consider
โข The best and most practical approach to implementing workplace discipline.
โข Three (3) key tips to maintain a disciplined workplace.
1. Maharashtra Biotechnology Policy 2001 Preamble:
ty
.in
1. The State of Maharashtra has always played a leadership role in the national economic and social
renaissance. It has looked at advances in science and technology as great opportunities for bringing
about economic transformation and social change. One great opportunity in this new century, rightly
termed as the 'Century of Knowledge', is the emergence of knowledge-based industries. Information
Technology (IT) was just a forerunner among these industries and Maharashtra responded rapidly
and became a leading State in IT. Another emerging opportunity on the horizon is Biotechnology.
2. Biotechnology deals with living systems, including plants, animals and microbes. Biotechnology
derives its strength by harnessing biological processes that sustain life. It incorporates any technique,
which uses living organisms, parts of organisms and enzymes, proteins, etc., which are either
naturally occurring or are derived from such living systems. Such techniques can be used to make or
modify the products, improve plant or animal productivity or develop microorganisms for special use.
Emerging Biotechnology uses recombinant DNA, cell fusion, embryo manipulation, etc.
3. Biotechnology has the potential to transform the lives of the people in the State by impacting hugely
on agriculture, animal husbandry, health, environmental protection, material transformation, etc.
Further, Maharashtra has the potential to become a leader in Biotechnology, not only in the country
but also in the entire world. It is to realize this potential that the State is announcing this
Biotechnology Policy 2001.
st
ri
al
pr
o
pe
r
4. Exciting biofuture:
Thanks to our increasingly deeper understanding of the intricate biochemical interactions at the
cellular and molecular levels, there are new paradigms in health care. We have moved from
'preventive' medicine (vaccines) and 'curative' medicine (antibiotics) to 'predictive and corrective'
medicine, thanks to the unravelling of the mystery of the human genome. We can now identify not
only the genes that cause a disease but also correct the defects through gene therapy. Recent
breakthroughs in stem cell research have, for the first time, given the hope that we may be able to
regenerate diseased organs, thus paving the way for 'regenerative' medicine.
w
w
w
.in
du
5. Agriculture contributes in a major way to our Gross National Product (GNP). The maximum impact of
Biotechnology will be felt in this sector. The Green Revolution transformed the country from one
perennially beset with food shortages and resultant hunger to one where the silos are overflowing. In
future, however, the State will face the problem of producing 'more from less', that is, more food from
less arable land, less water per capita, less polluting energy sources, etc. New Biotechnology holds
the promise of finding a solution to this problem through creation of high-yielding and disease and
drought resistant crops.
6. Thanks to the white revolution, we achieved the proud distinction of being the highest producer of
milk in the world. That quite often makes us forget that as much as 80 percent of this milk comes from
small and even marginal farmers, who own a single head of cattle. The individual yields are also
nowhere near the world average. This situation is to be radically changed by selective breeding of
high-yielding animals, which would profit not only the producers but also the consumers of milk.
Biotechnology thus has the promise of making the White Revolution sparkling white.
7. Bio-fuels will provide new sources of energy. Biopesticides will provide ecologically safe pest
treatments. Bio-fertilizers will provide safer and ecologically friendly fertilizers. Bioremediation, rather
than chemical treatment, can now convert hazardous wastes into useful products. Bioinformatics, with
confluence of information technology and biotechnology, for the first time is opening up exciting new
opportunities of unparalleled dimensions. Indeed, the future in the 21st century is 'bio-future' all the
way, and Maharashtra wants to be a participant in building this 'bio-future'.
Advantage Maharashtra:
8. The State derives its confidence that it will be a leader in Biotechnology based on its diverse
strengths. These strengths include its superior human resource, the excellence of its private and
public institutions, the superb infrastructure, and a conducive business environment as well as the
inherent strength of its industry. Equally important is the progressive and proactive government which
is prepared to go that 'extra mile' to make things happen. This confidence is not merely based on its
potential, but on its proven performance.
2. w
w
w
.in
du
st
ri
al
pr
o
pe
r
ty
.in
9. The Sahyadri range running along the entire western perimeter of the State is adorned with an
extremely rich flora. There are many plants with medicinal properties and essential oils. Many are
also of value to other industries like the detergent or tanning industries. Proper and comprehensive
documentation of this bio-diversity would lead to its conservation and to adding value to it. This
diverse and resplendent flora would prove to be a gold mine for the Biotechnology industry.
10. Look at these facts. Maharashtra produces around one-fifth of national industrial output and accounts
for 30% of exports (including in knowledge-based industries such as electronics and IT products,
drugs and pharma, etc.). It has 22% of the new Company registrations. It accounts for 30% of the
patents filed from India. It is one of the most urbanised States, with a per capita income that is 1.5
times the national average. It has registered 7% growth per annum in the last decade. The investor
confidence is the highest for Maharashtra with $ 12 billion in terms of Foreign Direct Investment
approvals and proposed industrial investment of Rupees 220,000 crore, both in the last ten years, the
highest in the country. Its success rate of implementation of projects is also the highest among major
States.
11. Mumbai is the financial capital of India. It is the hub of the country's financial services sector. The
Reserve Bank of India and the State Bank of India, NABARD, SEBI, etc., are headquartered in
Mumbai. The country's oldest and biggest stock exchange, the Bombay Stock Exchange, is in
Mumbai. Technology financing mechanisms and institutions in Maharashtra are some of the strongest
in India. The presence of venture capital companies such as ICICI, Rabo Bank, etc. provides the
much needed support in technology financing and development.
12. This overall confidence in the strength of the State gets easily reflected and translated into a 'biotech
advantage'. The biotech foundations in Maharashtra go back a long way. The Haffkine Institute,
established in 1899, is the oldest biotech institution in Maharashtra. In 1954, Pune created a
landmark in Biotechnology by becoming the first city in India to have an industry producing Penicillin,
the Hindustan Antibiotics Ltd. The plant was then the largest producer of Penicillin in the whole of
Asia. The vaccines produced by Serum Institute of India Ltd, the foremost and the largest
manufacturer of vaccines, sera and biologicals in India, reach every one out of four children in the
world! The Venkateshwara Hatcheries group is the largest producer of poultry vaccines in India
13. Maharashtra has the strength to make it the 'most preferred destination' for the pharmaceutical
industry, and to attract and accelerate investment in Drugs and Pharmaceuticals. Maharashtra
already contributes about 40% of the total turn over. It has 4,100 registered pharmaceutical
manufacturers out of the total of 20,053 in India. Most international companies have shown their
preference for Maharashtra. These include, among others, GlaxoSmithKline, Novartis, Pfizer,
Johnson & Johnson, Abbott, Aventis, Knoll, and many others.
14. Major Indian companies such as Wockhardt, CIPLA, LUPIN, Nicholas Piramal, etc. do not only have
their presence in Maharashtra, but they are also marching forward in the most challenging and
frontline areas of Biotechnology. Wockhardt is already entering biopharmaceuticals. Whereas Lupin
and Nicholas Piramal are moving in a major way in innovative drug research, the latter have made
major forays in pharmacogenomics. Reliance Life Sciences have made forays into stem cell research
and have already been recognized as one of the key suppliers of cell lines by the U.S. Government.
15. Agro-Biotechnology has strengthened its roots in the State through one of the largest seed producing
companies, MAHYCO, which supplies hybrid seeds to farmers throughout the country. Currently, it is
engaged in conducting field trials of transgenic seeds in collaboration with a multinational company.
The State's Agriculture Universities have made considerable headway in the field. The development
of molecular techniques has been initiated. Various research projects are in progress, and subject of
Biotechnology forms a part of the curriculum at all levels of study in the Agriculture Universities.
Components of Biotechnology in the form of tissue culture, bio-fertilisers and bio-pesticides have
already gained popularity in the State. As many as 21 tissue culture laboratories have been set up in
the Maharashtra.
16. The State has an excellent intellectual infrastructure. Through nearly 1000 institutions, it produces
around 163,000 trained technical personnel each year. The State has already set up specialised
parks for different sections including IT. The bio-industrial enterprises cannot sustain themselves
unless they are backed up by a highly trained and skilled human resource. Some of the best Centres
of excellence in India that are present in Maharashtra do precisely that. These include the Bhabha
Atomic Research Centre, Indian Institute of Technology, Tata Institute of Fundamental Research,
University Department of Chemical Technology, and the Cancer Research Institute, all at Mumbai.
3. 21.
w
w
w
.in
du
20.
st
ri
al
pr
o
19.
pe
r
18.
ty
.in
17.
They also include several life science and Biotechnology based departments of the University of
Pune, National Centre for Cell Science, National Institute of Virology, National Chemical Laboratory,
National Aids Research Institute, Agharkar Research Institute, Bharati Vidyapeeth's Institute of
Environment Education & Research and the Rajiv Gandhi Institute of Information Technology &
Biotechnology, the Vasant Dada Sugar Institute, all at Pune, as also the National Environmental
Engineering Research Institute at Nagpur. The Animal Diseases Investigations Laboratory, Pune
involved in diagnosis and research of animal diseases, especially in four States of the Western region
of the country, has been recognised as reference laboratory by Government of India. New forwardlooking initiatives in providing specialized education in Biotechnology, such as by the Vidya
Pratisthan's School in Biotechnology, have already begun to emerge. A number of defence research
establishments in the State have been engaged in conducting cutting edge research in Biomedicals,
Bioinformatics and Biotechnology.
This existing intellectual infrastructure is dynamic and responding to new challenges by creating new
institutions. As an example, an Advanced Centre for Treatment, Research and Education in Cancer
(ACTREC) in Navi Mumbai has two wings: one on basic research, which has been formed by
complete shifting of the present Cancer Research Institute (CRI) and also another institution, a
Clinical Research Centre. The exciting research agenda includes gene and antisense therapy,
immunotherapy, and stem cell transplantation. Modern biomedical research requires a chain of
hospitals and clinics which could establish clinical research organizations. Some of the best hospitals
in India are located in Maharashtra, giving that extra support and impetus.
Maharashtra State is the major sugar producer in India and it has the largest sugar belt. It also
happens to be a major contributor to agricultural wealth in the country.
Adding to these existing advantages is also the potential for future growth due to Maharashtra's
natural attributes. The natural availability of coastline 720 kilo metres in length, which is very
productive and rich in biodiversity, is yet another strength for important marine Biotechnology
ventures in the State. The existing well-knit infrastructure of the State Government could be
effectively explored not only for fisheries, aquaculture and marine plant Biotechnology, but could also
be exploited to harvest the marine microbes for diverse purposes, from new drug development to
solving the environmental problems of urban India. Fisheries and aquaculture would also form an
important industry for developing the newer food products and other derivatives.
Maharashtra has now emerged as a leading horticultural State in the country. Different types of soils,
diverse agro-climatic conditions, adequate technical manpower, well-developed communication
facilities, increasing use of drip irrigation, green houses, use of cold chain facilities and vibrant farmer
organizations offer wide opportunities for growing different horticultural crops in the State. The results
are there for all to see. Maharashtra produces 28% of banana, 28% of cashew, 64% of mandarin
orange, 38% of sweet orange and over 72% of the grapes in India and also, of course, the world
famous Alphonso mangoes! Chicoo production is unique to the coastal region of the State. Overall,
the State contributes 18% of the total fruit production in India. Although floriculture in the State is of a
very recent origin, after the entry of the private sector for business in cut flowers, Maharashtra
accounts for one-third of the business in India
Maharashtra has a large area that falls in the rain shadow region. However, even in the face of
natural obstacles such as water shortage and wastelands, the State has accomplished a dramatic
increase in horticultural production. This is indicative of the core competence of the State's farmers
and their determination to make sizeable contributions to the national exchequer.
Objectives:
22. To develop the Biotechnology industry in the State in order to:
โข Provide to the farmers of the State better, high-yielding, drought and pest-resistant crops suited to
the agro-climatic conditions of the State;
โข Help develop affordable and more cost-effective drugs and devices to counter diseases common
to India and to tropical and sub-tropical areas, and to reduce the disease burden;
โข Develop cheaper and effective technologies to purify water sources and to deal with industrial
effluents and urban wastes, etc.;
โข Improve the livestock in the State in order to increase the earning capacity in rural areas;
โข Improve the marine stock to improve the productivity of the fishing industry;
4. โข
โข
โข
โข
โข
Enhance the value and utility of medicinal plants and traditional systems of medicine by
developing new products with global potential;
Develop and promote utilization of animal diagnostics and vaccines for preventing losses and
increasing realization from livestock and poultry;
Augment feed and fodder availability and processing;
Improve the overall nutritional security in the State;
Improve the quality of life through better health and better environment.
pe
r
ty
.in
23. To lead the biotechnology industry in the State to a growth path from where it can become globally
competitive, the following steps would be taken:
โข Providing the appropriate policy framework which will smoothen its path;
โข Providing adequate infrastructure, especially in the form of Biotechnology Parks;
โข Providing an appropriate package of incentives;
โข Developing a world-class higher education and research base to serve the needs of a growing
Biotechnology industry and for creating high quality employment in the State;
โข Creating supporting institutions for the Biotechnology industry for the development of human
resource as well as for the applications of Biotechnology;
โข Simplifying the application of labour and other laws and procedures to accelerate the
development and growth of the biotechnology industry;
โข Facilitating new ventures and innovations.
w
w
w
.in
du
st
ri
al
pr
o
Strategic Initiatives:
Institutional Mechanisms:
24. The State realises that it requires a robust implementation strategy to fructify its vision to be a leading
Biotech State. Therefore, the State Government will take tangible and firm steps to realize the
ambitious goals. Towards this, two apex institutions will be created. The first will be the Maharashtra
Biotechnology Board, and the second will be the Maharashtra Biotechnology Commission. These will
be backed up by a Biotechnology Development Fund.
25. The Chief Minister of Maharashtra would preside over the Maharashtra Biotechnology Board. It will
have as its members, among others, eminent leaders in science and technology and also industry.
26. The Board would ensure proper and timely implementation of this Policy, which is essentially meant
to see that the social and economic benefits of the Biotechnology Revolution will be available to every
citizen of the state. It will act in a manner so that the Biotechnology industry in the State will retain its
competitive edge at all times. Towards this, it will liaise with the Central Government to remove all the
impediments that come in the way of the growth of Biotechnology in India.
27. With a public-private partnership, the Government will set up a special Biotechnology Development
Fund with an initial corpus of Rs. 50 Crores. This Fund will receive annually a specially earmarked
contribution of 1% from the annual Plan funds from different departments of the State Government,
who are likely to be the beneficiaries of the Biotechnology Revolution. The Fund can be further
augmented by grants and donations from overseas for financing different ventures.
28. The Board will be supported by the Maharashtra Biotechnology Commission, which will be the key
implementation body. It will have an eminent scientist as its Chairman, with knowledgeable
professionals from academia, industry, as well as the concerned government officials as its members.
29. The Commission will be responsible for effective utilization of the Biotechnology Development Fund.
The Commission will act as a think tank and key advisor to the Maharashtra Biotechnology Board on
diverse policy related issues. It will identify areas where the investments by the State in biotech
interventions in a proactive manner will lead to large economic and social benefits for the State. It will
promote research in the emerging and nascent technology areas by inviting proposals from different
institutions and industrial enterprises. It will assess and then approve the proposals for financial
grants from the Fund. It will also be responsible for the management of the Resource Centre and
Business Facilitation Centre to be located at the Pune Biotechnology Park. The Commission will also
review diverse aspects of biosafety approvals for genetic engineering interventions and coordination
of activities at the State level. The Commission will help the State in creating greater public
awareness about issues arising from new Biotechnology, which impinge on diverse aspects of
culture, morality, ethics, economics, etc.
5. .in
du
st
ri
al
pr
o
pe
r
ty
.in
State as an Enabler and a Facilitator:
30. The State specifically intends to facilitate for the farmers the provision of high yielding and drought
and pest resistant varieties of crops that are genetically modified to thrive in the prevalent agroclimatic conditions. Crops where such biotechnological interventions can yield beneficial results will
be identified. Taluka-level seed farms, farms of the Agricultural Universities and lands in the
Maharashtra Industrial Development Corporation (MIDC) areas will be made available to
Biotechnology units so that field trials and seed multiplication of approved varieties can be
undertaken. It will be ensured that all laws of the land and regulations will be followed so that a
'responsible Biotechnology' will be promoted in the State.
31. Biotechnology companies located in the State will be permitted to acquire and own agricultural lands
in excess of the current ceiling limits provided they are being specifically utilized for experimentation
and field trials, which are a logical part of the research and development chain.
32. The State has a vast public health machinery and therefore invaluable data at its command. It will
share these data with the Biotechnology companies in a transparent and ethical manner. The public
health machinery of the State will also actively collaborate with Biotechnology companies in clinical
research by following internationally accepted norms.
33. Maharashtra's Food and Drug Administration (FDA) is one of the most progressive and competent in
the country. The FDA will play a facilitating role in the growth and development of pharmaceutical and
food processing Biotechnology industry. Several vaccine-producing units are in the State-controlled
public sector. These will serve as valuable allies to the Biotechnology industry. Similar measures will
be taken for the livestock and fishery industries also.
34. Proper treatment of urban wastes and industrial effluents is of crucial importance to the State, with its
concern for the maintenance of the region's ecology. Municipal bodies and organizations such as
CIDCO, MHADA, MJP and MIDC, which presently deal with these problems, will take up joint projects
with Biotechnology companies for developing effective technologies for converting wastes into useful
products and to purify water, thereby aiding its conservation. The existing infrastructure and data
available with these undertakings will be made available to the Biotechnology companies for
experimentation and trials.
35. In pursuance of its new Industrial Policy 2001, the State has declared its intention to amend certain
provisions of the Industrial Disputes Act and the Contract Labour Act, subject to the approval of the
Central Government (since these are Central laws) and the Legislature. The amendments would
apply to Biotechnology units covered under these Acts. Moreover, in the case of Biotechnology units
within the purview of the Shops and Establishments Act, restrictions on shift working, working hours
and employment of women would be relaxed, as has been done in respect of Information Technology
units.
w
w
w
Financial Incentives:
36. Government will make the industrial power tariff applicable to all Biotechnology industries engaged in
the production of high-end products. This benefit will be applicable to both new and old companies.
Additionally, agricultural Biotechnology companies will be given power at agricultural rates. All
Biotechnological industries will be exempted from statutory power cuts.
37. Biotechnology units will be exempted from paying electricity duty. Captive power generation will be
permitted to Biotechnology units throughout the State. Public bodies or their joint ventures will be
permitted to establish 'Independent Power Producers' for the dedicated provision of power to
Biotechnology Parks promoted by them.
38. Sales tax/value added tax on Biotechnology products would be decided as per recommendations of
the empowered committee at the national level. A methodology to define Biotechnology products
would be evolved. Definition of Biotechnology products would be decided by the Central Government
or it would be finalised in consultation with the Task Force appointed by the State Government.
39. Biotechnology units throughout the State will be eligible for all the benefits available to industrial units
located in 'D' areas of the State under the New Package Scheme of Incentives, 2001, except in the
D+ and 'No Industry District' areas, where such units will be eligible for benefits in the D+ and 'No
Industry District' areas. These include capital subsidy for small-scale Biotechnology units, and refund
of octroi and similar levies.
40. New Biotechnology units, and expansions of existing units, will be exempted from payment of Stamp
Duty and Registration fees in C, D, D+ and No Industry Zones in terms of Package Scheme of
6. pe
r
ty
.in
Incentives, 2001 of the State. In other areas, such exemption will be extended to units in
Biotechnology Parks promoted by public bodies. In private Parks, such Stamp Duty and Registration
fees would be waived to the extent of 50%. In addition, only 10% of the admissible Stamp Duty would
be payable on property transactions resulting from amalgamation of Biotechnology companies.
41. Twice the admissible Floor Space Index would be admissible for Biotechnology units in Parks
promoted by MIDC and other public bodies, and at other designated locations.
42. Information Technology and Biotechnology are fuelled by continuous generation and advancement of
new knowledge. Therefore, the locations of all such undertakings will be treated as 'Knowledge
Processing Zones' and will be given special privileges. For example, Information Technology
undertakings have already been enjoying certain privileges in view of their special status. The
Government recognises that the role of bioinformatics centres, which symbolize the confluence of
Biotechnology and Information Technology, is crucial to the development and sustenance of the
Biotechnology industry. Therefore, all such centres will also be treated on par with Information
Technology units, and all the incentives applicable to Information Technology units will be extended
to these centres.
43. The Government will encourage setting up world class "Centres of Excellence", which will cover all
aspects of cutting edge research and development in emerging areas of life sciences and technology.
To facilitate this, the Government will offer land at concessional rates to Centres of Excellence in the
area of Biotechnology. Specific norms will be laid down to define such Centres, and each prospective
Centre will be subjected to scrutiny and approval on an individual basis.
st
ri
al
pr
o
Incentives for Promoting Biotechnology Parks:
44. The State Government will promote setting up of Biotechnology Parks, Research and Development
Centres and pilot plant facilities for undertaking contract research by putting equity stakes in such
projects. The Government equity would be in kind, such as in the form of land allotted for the projects.
45. Units engaged in agricultural Biotechnology ventures will be designated as agricultural industries with
extension of all the incentives, exemptions and benefits accruing to that industry. Further, MIDC will
allot land to such industrial units in areas under its jurisdiction at industrial rates.
w
w
w
.in
du
Infrastructural Support:
46. The Government is aware of the important role of a supportive infrastructure in the growth and
development of any industry. It will, therefore, lay great emphasis on the quality of infrastructure that
is made available to the industry.
47. Unlike other industries, Biotechnology industries are crucially dependent on highly skilled personnel
at all levels of their operations. The centres supplying such manpower at present will therefore have
to be strengthened and diversified. Biotechnology Parks will be set up at Pune (pharma
Biotechnology), Shendre/Jalna and Akola (agricultural Biotechnology).
48. Among other routine facilities common to any Technology Park, these Parks will offer โข GMP facilities in conformity with US FDA norms;
โข Business Facilitation Centres (BFC), which will offer services to the clients of the Park so that a
hassle-free environment is created in the Park. The services to be provided to the clients through
BFC will comprise:
i. A cell for facilitating rapid regulatory and customs clearances and interface with Government
bodies;
ii. Handholding services to entrepreneurs in getting power connection, telephone connection, etc.;
iii. Technology transfer and access services;
iv. Commercialization services;
v. Networking with research institutions;
vi. Mentoring and information and support on intellectual property protection, etc.
The BFC will also maintain databases on Biotechnology and also deal with quarantine issues.
Initially, it is planned to have experts in regulatory affairs, Biotechnology, and marketing. There
will be adequate supporting staff to assist these experts. Also, the BFC will be equipped with all
the necessary facilities to provide secretarial services, communication services, etc.
โข Connectivity with academic and research institutions for providing the necessary human resource
development base.
7. โข
Physical infrastructure such as quality power, telecommunication, connectivity, adequate
bandwidth, reliable water supply etc.
โข Land for building residential complexes for scientists and Biotechnology professionals, complete
with schooling and recreational facilities.
49. The Government will create a Biotechnology Resource Centre, a reference centre for certification of
products after testing them intensively, and an experimental animal facility that will meet all the
ethical, legal and safety standards. Land will be made available for these purposes. The State
Government may undertake civil construction work for these facilities depending on contributions from
the industry or from charitable institutions. The State will actively seek participation in the setting up
and running of these special facilities from NRI and academic and other organizations overseas.
50. The Biotechnology Parks and the Resource Centre will evolve new patterns of collaboration between
research scientists, industry personnel, extension workers, farming community and the consumers for
wider dissemination and better understanding of the costs and benefits of Biotechnology.
al
pr
o
pe
r
ty
.in
Taking BT to the People:
51. Acceptance of Biotechnology-mediated products by the consumers would be of paramount
importance to the continued flourishing of the Biotechnology industry. The State Agricultural
Universities have demonstrated their mettle in such non-formal education of consumers as well as
farmers through their extension programmes. The Educational Media Research Centre (EMRC) of
the Pune University is also well equipped to carry out such programmes. These organizations will be
encouraged to take up specific projects for wider dissemination of Biotechnology
52. The State will also emphasize the importance it attaches to Biotechnology by observing a State
Biotechnology Day on 14th November, the birth anniversary of Jawaharlal Nehru, who embodied
independent India's commitment to science and technology. The purpose of this Day will be to carry
the message that Biotechnology can be a key 'life care tool' of the twenty first century to the public at
large by improving food, health, environment, etc. in a major way. The Biotechnology Commission will
work out details of each year's programme.
w
w
.in
du
st
ri
Intellectual Property Rights:
53. The Government realizes that one of the foremost concerns amongst the industry as well as the
research community would be one revolving around protection of intellectual property rights. The
Government will, therefore, launch programmes to create awareness about IPR among the users as
well as society in general. The latter component would be tackled through a special manpowertraining programme to be developed at the University of Pune, which has already pioneered the
forays into IPR by setting up the first CSIR Chair in IPR. In addition, a special course will be
introduced at the postgraduate level in the HRD programmes so as to cover various aspects of IPR. It
will also be necessary to revise and create new curricula for the law faculty in order to incorporate
Patent Law and International IPR related law courses This will be accorded high priority.
w
Back to the future:
54. While it is true that there has been a distinct, even dramatic improvement in the living standards of a
large section of the population, many other basic needs of the people remain to be adequately met.
Maharashtra has the inherent potential and the necessary will not only to solve these problems
satisfactorily but also to leapfrog into an era of economic prosperity. The State is confident that
setting up this bold and visionary Biotechnology Policy will set the mood and tone for taking
Maharashtra on the path of sustainable development which ensures for its citizens the very best of
food, nutrition, health, environmental and livelihood security.